Y90 Radioembolization for Locally Advanced HCC

UCLA Health

S. Padia

Understanding HCC: Perspectives on Diagnosis, Risk Factors, and Trea…

Yale Cancer Center

A. Jaffe

Combined Hepatocellular-Cholangiocarcinoma: Diagnosis and Management

Integrity CE

J. Birkness-Gartman

HCC Percutaneous Radio-Ablation Using BAT-90: Results of an Ongoing …

Malkhaz Mizandari

Advanced HCC: When to Switch to 2L Treatment - Case Presentation

COR2ED The Heart of Medical Education

T. Vandamme

New Guidelines in the Management of Liver Cancer

Yale Cancer Center

T. Taddei

ASCO® GI 2024 Insights: "Evaluating Novel Therapies and ctDNA as a M…

Insights from 2024 ASCO® GI Annual Meeting

R. Mukherji

Intermediate Stage HCC With No Hx of Cirrhosis: Case Presentation an…

Integrity CE

M. Baretti, D. Hsieh, K. Lafaro, F. Escorcia

Year in Review: GI Radiation Oncology

OncoAlert

E. Miller

Hepato-Oncology: Highlights from AASLD 2024

Northwestern Medicine Gastroenterology

L. Kulik

Gallbladder and Bile Duct Cancer: Improving Screening & Treatment Op…

Oncology Data Advisor

M. Hadfield, W. Haque

Intermediate Stage HCC With a Hx of Cirrhosis: Case Presentation and…

Integrity CE

M. Baretti, D. Hsieh, K. Lafaro, F. Escorcia

Advances in Hepatocellular Carcinoma Diagnosis and Treatment

Scripps Health

A. Singal

Liver Cancers: Hepatocellular Carcinoma & Cholangiocarcinoma - Curre…

Houston Methodist

A. Connor, A. O. Kaseb, S. Kodali

Disparities Through GI Cancers: Panel Discussion

Total Health

R. Kim, J. Starr

ASCO® GI 2024 Insights: "Clinical Validation of Northstar Response, …

Insights from 2024 ASCO® GI Annual Meeting

I. Sahin

Approach to the Patient with a Liver Mass

Cedars Sinai

W. Ayoub

ASCO GI 2023 NRG/RTOG 1112 Randomized Phase 3 Study: Sorafenib vs. S…

ASCO GI 2023 Conference Coverage

L. Dawson

Hepatocellular Carcinoma - From Screening to Treatment: Current Prac…

Yale Cancer Center

T. Taddei

The Global Landscape of Nonalcoholic Fatty Liver Disease: Results Fr…

Yichen Wang